Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| VMR2022-03 | Other Grant/Funding Number | Michigan, State of, Licensing and Regulatory Affairs, Department of 573000 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Michigan, State of, Licensing and Regulatory Affairs | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of the MIVetsCan Can-Coach Trial is to test four coaching sessions to help Veterans with chronic pain use their own cannabis products more effectively to manage pain and related symptoms.
All study interactions will be done virtually.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Immediate Education | Experimental | Education sessions starting ~ week 4 of trial |
|
| Waitlist Control - delayed education | Other | Education sessions starting ~ week 12 of trial |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Educational Session | Behavioral | The initial session will last about 45 to 60 minutes. The subsequent 3 sessions are anticipated to take about 20-30 minutes. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Patient Global Impression of Change (PGIC) score | Up to 14 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Self-report of pain (intensity or severity) from a numerical rating scale of 0-10 | Self report of pain from a numerical rating scale of 0-10 over 7 day epochs where a higher number score indicates more pain | Up to 14 weeks |
| Anxiety as measured by the score on the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 Profile version 2.1 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Catherine Klida | Contact | 734-998-8010 | crklida@umich.edu |
| Name | Affiliation | Role |
|---|---|---|
| Kevin Boehnke, PhD | University of Michigan | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Michigan | Recruiting | Ann Arbor | Michigan | 48105 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D059350 | Chronic Pain |
| D002189 | Marijuana Abuse |
| ID | Term |
|---|---|
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Participants will be randomized to immediately receive 4 sessions of tailored guidance or to receive it after 12 weeks, as a waitlist control condition.
Not provided
Not provided
Not provided
Not provided
| Up to 14 weeks |
| Pain interference trends as measured by the score on the PROMIS-29 Profile version 2.1 | Up to 14 weeks |
| Sleep disturbance as measured by the score on the PROMIS-29 Profile version 2.1 | Up to 14 weeks |
| Suicidal ideation as measured by the Positive and Negative Suicide Ideation (PANSI) - Positive ideation | Up to 14 weeks |
| Suicidal ideation as measured by the Positive and Negative Suicide Ideation (PANSI) - Negative ideation | Up to 14 weeks |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |